{
  "zip": "1202",
  "sector": "Healthcare",
  "fullTimeEmployees": 10,
  "longBusinessSummary": "Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief in serious diseases with high unmet medical need. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG is based in Geneva, Switzerland.",
  "city": "Geneva",
  "phone": "41 44 723 59 59",
  "country": "Switzerland",
  "companyOfficers": [],
  "website": "http://www.relieftherapeutics.com",
  "maxAge": 1,
  "address1": "Fondation EIP",
  "fax": "41 44 726 90 12",
  "industry": "Biotechnology",
  "address2": "BAtiment F2/F3 Avenue de SÃ©cheron 15",
  "previousClose": 0.358,
  "regularMarketOpen": 0.366,
  "twoHundredDayAverage": 0.3524,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.38,
  "navPrice": null,
  "averageDailyVolume10Day": 5208700,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.358,
  "fiftyDayAverage": 0.3524,
  "trailingAnnualDividendRate": null,
  "open": 0.366,
  "averageVolume10days": 5208700,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -22.710985,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.35,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 4610610,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1127077760,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 5208700,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.35,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 4610610,
  "fiftyTwoWeekHigh": 0.382,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.307,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.38,
  "exchange": "PNK",
  "shortName": "RELIEF THERAPEUTICS HOLDING AG",
  "longName": "Relief Therapeutics Holding AG",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RLFTF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_275741064",
  "uuid": "242a4262-cd96-3206-8276-87602eb570d0",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 3246729984,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.44918,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.063140005,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 1255810055,
  "enterpriseValue": 844980224,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.366,
  "logo_url": "https://logo.clearbit.com/relieftherapeutics.com"
}